
Genetic Navigation: A Narrative Review of XRCC1 Polymorphism Impact on Platinum-Based Chemotherapy Outcomes in NSCLC ...
Introduction Non-small cell lung cancer (NSCLC) is the most common type of lung cancer worldwide, comprising approximately 85% of all reported cases.1,2 Globally, the 5-year survival rate for NSCLC is less than 20%.3 Most NSCLC patients are diagnosed at an …